EM Systems CoFRA:EMO +0.78%76 EBITDA Margin % is 25.45% as of Dec. 2025, which is 8% above its 10-year median of 23.49. GuruFocus rates FRA:EMO with a GF Score™ of 76/100 and a GF Value™ of €3.96. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, EM Systems Co ranks better than 65.72% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. EM Systems Co's EBITDA for the
three
months ended in Dec. 2025 was €7.7 Mil. EM Systems Co's Revenue for the
three
months ended in Dec. 2025 was €30.4 Mil. Therefore, EM Systems Co's EBITDA margin for the quarter that ended in Dec. 2025 was 25.45%.
EM Systems Co (FRA:EMO) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
EM Systems Co EBITDA Margin % Related Terms
EM Systems Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for EM Systems Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:EMO vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, EM Systems Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EM Systems Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EM Systems Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where EM Systems Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EM Systems Co (FRA:EMO) has a EBITDA Margin % of 25.45% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EM Systems Co and its competitors. This is near median its historical median of 23.49. Over the past decade, EM Systems Co's EBITDA Margin % has ranged from 16.16 to 30.06. According to the industry distribution chart, EM Systems Co ranks #229 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 34.3%.
Is EM Systems Co's EBITDA Margin % too high?
EM Systems Co's current EBITDA Margin % of 25.45% is near median its 10-year median of 23.49. Over the past 10 years, this metric has ranged from a low of 16.16 to a high of 30.06. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. EM Systems Co's value of 25.45% is 149.3% above this industry median. Based on the distribution chart, EM Systems Co ranks #229 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, EM Systems Co has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does EM Systems Co's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EM Systems Co ranks #229 out of 668 companies for EBITDA Margin %. This puts EM Systems Co in the upper half of its industry. The industry median EBITDA Margin % is 10.21. EM Systems Co's value of 25.45% is 149.3% above this benchmark. Historically, EM Systems Co's own EBITDA Margin % has ranged from 16.16 to 30.06 over the past decade. While the company's 10-year median is 23.49 vs. the industry median of 10.21, EM Systems Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EM Systems Co's current EBITDA Margin % of 25.45% is 149.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EM Systems Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EM Systems Co's current EBITDA Margin % is 25.45%, which is near median its own 10-year median of 23.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EM Systems Co stock overvalued right now?
EM Systems Co (FRA:EMO) has a current EBITDA Margin % of 25.45%. The stock's GF Value™ is €3.96, compared to a current price of €2.58 — trading 34.8% below its estimated fair value. The current EBITDA Margin % is 25.45%, which is near median its 10-year median of 23.49 and 149.3% above the Healthcare Providers & Services industry median of 10.21. EM Systems Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For EM Systems Co (FRA:EMO), the current EBITDA Margin % is 25.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EM Systems Co (FRA:EMO) Overvalued in 2026?
Based on GuruFocus' analysis, EM Systems Co stock appears to be undervalued.
The current stock price of €2.58 is trading 34.8% below its estimated GF Value™ of €3.96.
Key valuation signals for FRA:EMO:
EBITDA Margin %: 25.45% (near median its 10-year median of 23.49)
GF Value™: €3.96 vs. price of €2.58 (34.8% below fair value)
Industry Position: 149.3% above the Healthcare Providers & Services median (#229 of 668)
No single metric tells the full story. See the FRA:EMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EM Systems Co Ltd is a Japan-based company that develops, sells, and maintains systems for the medical (clinics and insurance pharmacies) and nursing/welfare industries. It operates its business in three divisions: Pharmacy System Business develops and sells systems for pharmacies, and provides related supplies and maintenance services; Medical system involved in the development and sales of medical office administration computer systems for medical institutions and clinics; Nursing Care/Welfare Systems Business products are systems for nursing care/welfare service providers and medical and nursing care collaboration solutions; Other businesses operates through its subsidiray that provides promotes cashless payments for clinics and pharmacies and Others services.
76GF Score
Get the complete analysis for FRA:EMO
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:EMO has been successfully added to your 
